Company intelligence
argenx
United in our commitment to improve the lives of patients
Biotechnology Research
Boston, US
2,315 employees
Founded 2008
4 public signals
About argenx
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
Verified activity
Signals from argenx
4 published signals
Presence & Recognition
argenx represented colleagues from Medical Affairs, Clinical Development, and Patient Advocacy at the ETA2026 event in Porto to connect with the global thyroid community.
Reported by Kelly Hogan
People
argenx welcomed Erin Quinn Sheehan, PHR, CCA, to join the US Commercial organization.
Reported by Erin Quinn Sheehan, PHR, CCA
People
argenx is hiring for a growing team of passionate people who want to make a real difference and be part of the journey.
Reported by Sandrine Piret-Gerard
People
argenx posted 40 new positions in US Commercialization including 12 Market Heads, 24 Business Leaders, and 4 HCP Marketing Community Leads.
Reported by Jeff Kennedy